Navigation Links
U.S. EPA Approves Registration of Antimicrobial Copper Alloys
Date:3/25/2008

Copper, brass and bronze kill pathogens - including 'superbug'

MRSA-responsible for hospital- and community-acquired infections

NEW YORK, March 25 /PRNewswire/ -- The U.S. Environmental Protection Agency (EPA) has approved the registration of antimicrobial copper alloys, with public health claims. These public health claims acknowledge that copper, brass and bronze are capable of killing harmful, potentially deadly bacteria. Copper is the first solid surface material to receive this type of EPA registration, which is supported by extensive antimicrobial efficacy testing.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080325/NYTU054 )

The EPA registration is based on independent laboratory testing using EPA-prescribed protocols that demonstrate the metals' ability to kill specific disease-causing bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). MRSA is one of the most virulent strains of antibiotic-resistant bacteria and a common cause of hospital- and community-acquired infections.

Testing under EPA-approved protocols demonstrates that copper, brasses and bronzes are effective against a number of disease-causing bacteria. For example, one study shows that on copper alloy surfaces, greater than 99.9% of MRSA "superbugs" are killed within two hours at room temperature.

The following statements are included in the registration: "When cleaned regularly, antimicrobial copper alloys surfaces kill greater than 99.9% of (specific) bacteria within two hours, and continue to kill more than 99% of (these) bacteria even after repeated contamination," and, "The use of a copper alloy surface is a supplement to and not a substitute for standard infection control practices; users must continue to follow all current infection control practices, including those practices related to cleaning and disinfection of environmental surfac
'/>"/>

SOURCE The Copper Development Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arizona Senate Approves Smoking Cessation Treatments for State Medicaid Beneficiaries
2. CMS Approves Home Sleep Testing for Diagnosis of OSA; AASM Experts Available for Comment
3. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
4. FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
5. FDA Approves Luvox(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
6. FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
7. U.S. Court Approves AK Steels VEBA Health Care Settlement With Middletown Works Retirees
8. Securian Board Approves 8 Officer Promotions
9. MGT Capital Investments, Inc. Approves Share Buyback Program
10. Kaiser Permanente Approves $29 Million in Community Benefit Grants
11. Otter Tail Corporation Reports Record Revenues and Net Income From Continuing Operations for 2007; Earnings Per Share of $1.78; Board Approves Dividend Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...c. 4 While Congress deb...th care costs, Leapfrog,s purchaser members point ...ering the best quality care in the nation while at...our urban, eight children,s and three rural hospit...ased on results from The Leapfrog Hospital Survey....
(Date:12/4/2009)...tists at Johns Hopkins publishing in the December ...e by a gene called "Twist" may be the proverbial r... that drive aggressive, metastatic breast cancer f...ent work suggesting that it is a relatively rare s... breast cancer, scientists have surmised that this...
(Date:12/4/2009)...ntal tourism is a phenomenon that was started by p...high price of dental work in the US, Canada, and o...ental care, people have found that Mexican Dental ...tination. , (PRWEB) Decem...an 6 years, Mexican Dental Vacation is seeing thei...
(Date:12/4/2009)...RNewswire/ -- Substantial progress has been made o...s ability to diagnose and treat epilepsy and its c...ement has not reached most of the 50 million peopl...hree million people in the United States who have ...er, M.D., president of the American Epilepsy Socie...
(Date:12/4/2009)...ering drugs known as statins are among the most pr...researchers at Fred Hutchinson Cancer Research Cen...ransplant patients from one of the most serious co...ft-versus-host disease, or GVHD. The findings are ...l Blood . , In a retrospective study of 567 pati...
Breaking Medicine News(10 mins):Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2
...r osteoarthritis of the knee back to the future.Th...helps relieve pain and other symptoms better than ...ation of leeches to treat pain is an ancient medic...s, such as in treating postoperative complications...
...by viral cold are common in preschoolers. These at... frequency disappears by school age. //The current...eroids at the first sign of an attack. But whether...atory symptoms or the need for hospital admission....
...diagnosed with type 2 diabetes and now research sh...eater risk for a heart attack and stroke. //Specif...d with type 2 diabetes are 14-times more likely to...oing to get heart disease, heart attacks and strok...
...soon be fighting a losing battle. Scientists from ...uccessfully stopped the tuberculosis pathogen's ab...cally hides out in the immune system in a cell cal...s TB. Thus far, all of the research has been done ...
...on condition that can be fatal. It is defined as a...lly due to a blood clot, //which blocks a coronary...for a pulmonary embolism, a new study shows a new ...t 600,000 Americans develop a pulmonary embolism a...
...eir mouths. But as children get older, they become...y if they have not tried it before. Green veget... scientists say thousands of years ago toxins in p...ous of certain food types as youngsters. Resear...
Other Medicine News:
(Date:12/4/2009)...Neb., Dec. 4 Amber Pharmacy announ...creditation Commission for Health Care, Inc. (ACHC... years, Amber Pharmacy has provided comprehensive ...ique needs of specialized conditions. Amber Pharma...transplant programs. They work with over 170 trans...
(Date:12/4/2009)...AKE CITY, Dec. 4 Dynatro... signed a sole-source vendor agreement to provide ...Physical Therapy with 65 clinics located in Tennes...d the sole-source supplier to Benchmark Physical T...esident of sales and marketing at Dynatronics. "Be...
(Date:12/4/2009)..., WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ ...eport published by the Pharmaceutical Research a...fies 97 new drugs and vaccines in development for ...ort found that the 97 products in development inc...e either in human clinical trials or awaiting appr...
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 1FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 2FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 3FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 4FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 5FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 6FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 7U S Census Bureau Daily Feature for July 21 52174 1UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 1UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 2UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 3UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 4
...A-H-M-S,Aktiengesellschaft today announced it has ...ministration (FDA) to market its patented B-R-A-H-...ic Peptide (ANP) is predominantly produced in the ...uretic peptides in the,circulation. ANP is involve...ovascular homeostasis. Although this peptide is un...
...an autoimmune disease that leads to thickening and... failure of internal organs, including the lungs, ...h the Scleroderma Foundation estimates affects app...here is no cure. A major and incapacitating compli... on the patients, fingers and toes that are very p...
Other Medicine Technology:FDA Submission of B-R-A-H-M-S MR-proANP Kryptor 2New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds 2New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds 3
Surgiflex® WAVE XP™ Handpiece and Pump, without probe shaft
Surgiflex® WAVE XP™ Handpiece and Pump
SUCTION IRRIGATION: StrykeFlow PS
SUCTION IRRIGATION: StrykeFlow 2
Medicine Products: